Medications

Ligelizumab safely, effectively treats hives

(HealthDay)—Ligelizumab appears to be a safe and effective treatment option for chronic spontaneous urticaria, according to a study published in the Oct. 3 issue of the New England Journal of Medicine.

Diseases, Conditions, Syndromes

Omalizumab effective for chronic spontaneous urticaria

(HealthDay)—Omalizumab, alone or in combination with a short-term course of corticosteroids, is highly effective for the treatment of refractory chronic spontaneous urticaria (CSU), according to a study published online ...

Immunology

CRP levels potentially useful in chronic spontaneous urticaria

(HealthDay)—C-reactive protein (CRP) levels are frequently elevated in patients with chronic spontaneous urticaria (CSU), and these elevations are relevant and potentially useful in management of the condition, according ...

Immunology

Cause of spontaneous hives pinpointed by clinical study

Melbourne researchers have solved a longstanding mystery about why some people develop recurring, itchy hives without an apparent allergic trigger, a condition known as chronic spontaneous urticaria (CSU).

Immunology

Asthma drug helps patients with skin disorder

Patients who develop itchy wheals in response to cold or friction benefit from treatment with omalizumab, a drug normally used to treat asthma. Two separate clinical studies, conducted by researchers from Charité - Universitätsmedizin ...

Immunology

Omalizumab effective for chronic spontaneous urticaria

(HealthDay)—Omalizumab is effective in patients with moderate-to-severe chronic spontaneous urticaria (CSU) symptoms and angioedema unresponsive to high doses of antihistamine treatment, according to a study published online ...

Immunology

Aspirin may exacerbate chronic urticaria in children

(HealthDay)—In some children with chronic spontaneous urticaria (CSU), exacerbations may be caused by hypersensitivity to aspirin, according to research published online Oct. 29 in Allergy.

page 1 from 2